Kai Li

7.5k total citations · 3 hit papers
212 papers, 5.4k citations indexed

About

Kai Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kai Li has authored 212 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Molecular Biology, 99 papers in Cancer Research and 28 papers in Oncology. Recurrent topics in Kai Li's work include Cancer-related molecular mechanisms research (53 papers), RNA modifications and cancer (46 papers) and MicroRNA in disease regulation (42 papers). Kai Li is often cited by papers focused on Cancer-related molecular mechanisms research (53 papers), RNA modifications and cancer (46 papers) and MicroRNA in disease regulation (42 papers). Kai Li collaborates with scholars based in China, United States and Japan. Kai Li's co-authors include Huanjie Yang, Yu Chen, Qinghua Zhao, Hangrong Chen, Ming Ma, Jingwei Feng, Jianlin Shi, Shige Wang, Qingzhu Yang and Bin Liu and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Kai Li

207 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus

2014 338 citations Kai Li et al. profile →
RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner

2020 285 citations Kai Li et al. profile →
A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study

2022 145 citations Kai Li, Yusheng Lin et al. profile →

Peers

Kai Li

ONCOL

IMMUN

Jiangning Chen China

Junfeng Zhang China

Shengfang Ge China

Junhua Wu China

Hui Lin China

Rui Xie China

Qing Miao China

Yong Dai China

Dongsheng Zhang China

Nian Liu China

Jiangning Chen China

Kai Li

2.8k ×0.9

1.3k ×0.7

905 ×1.3

419 ×0.7

ONCOL

753 ×1.3

IMMUN

Citations per year, relative to Kai Li Kai Li (= 1×) peers Jiangning Chen

Countries citing papers authored by Kai Li

Since Specialization

Citations

This map shows the geographic impact of Kai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Li more than expected).

Fields of papers citing papers by Kai Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Li. The network helps show where Kai Li may publish in the future.

Co-authorship network of co-authors of Kai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Li. A scholar is included among the top collaborators of Kai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Li. Kai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Hang, et al.. (2024). Microfluidics, an effective tool for supporting phage display-A review. Analytica Chimica Acta. 1326. 342978–342978. 1 indexed citations

Zhang, Zhenkai, Yajuan Zheng, Ruifeng Wang, et al.. (2024). Untargeted serum and gastric metabolomics and network pharmacology analysis reveal the superior efficacy of zingiberis rhizoma recens-/euodiae fructus-processed Coptidis Rhizoma on gastric ulcer rats. Journal of Ethnopharmacology. 332. 118376–118376. 7 indexed citations

Xiang, Hua, Xindan Zhang, Cheng Peng, et al.. (2024). A facile strategy for the construction of a phage display cyclic peptide library for the selection of functional macrocycles. Chemical Science. 15(30). 11847–11855. 7 indexed citations

Shi, Yunxing, Kai Li, Yichuan Yuan, et al.. (2024). Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma. Cancer Cell International. 24(1). 138–138. 2 indexed citations

Li, Kai, Rui Wang, Guowei Liu, et al.. (2024). Refining the optimal CAF cluster marker for predicting TME-dependent survival expectancy and treatment benefits in NSCLC patients. Scientific Reports. 14(1). 16766–16766. 7 indexed citations

Mai, Rongyun, Zhihong Tang, Xiaobo Wang, et al.. (2024). Ubiquitination of P53 Regulated by Ubiquitin-Specific Protease 14 Delays the Invasion of Hepatitis B Virus and the Development of Hepatitis. Viral Immunology. 37(9). 432–439.

Cao, Wenwu, Tianyu Li, Kai Li, et al.. (2024). Unleashed Remarkable Energy Storage Performance in Bi _0.5 K _0.5 TiO ₃ ‐based Relaxor Ferroelectrics by Local Structural Fluctuation. Angewandte Chemie. 137(4). 2 indexed citations

Yu, Lidong, Yi Wang, Kai Li, et al.. (2023). Metformin-based carbon dots based on biguanide functional groups for simultaneous chelation of copper ions and inhibitable colorectal cancer therapy. Carbon. 212. 118095–118095. 21 indexed citations

Xu, Xinxin, Yang Li, Kai Li, et al.. (2022). MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2. Cancer Biology and Medicine. 19(12). 1–23. 11 indexed citations

10.

Hu, Yongwei, Yanteng Xu, Rachel L. Mintz, et al.. (2022). Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis. Biomaterials. 293. 121942–121942. 40 indexed citations

11.

Wang, Lu, Jinghua Pan, Zhimeng Yao, et al.. (2022). Targeting PELP1 Attenuates Angiogenesis and Enhances Chemotherapy Efficiency in Colorectal Cancer. Cancers. 14(2). 383–383. 6 indexed citations

12.

Zou, Zhilin, Shu‐Guang Zhou, Guosheng Liang, et al.. (2021). The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators. Molecular Omics. 17(3). 438–453. 21 indexed citations

13.

Zou, Zhilin, Shu‐Guang Zhou, Guosheng Liang, et al.. (2021). Correction: The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators. Molecular Omics. 17(4). 641–641. 1 indexed citations

14.

Zhang, Xiaoqing, Muhammad Akhtar, Lijun Yang, et al.. (2021). NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44. Oncogene. 40(35). 5427–5440. 22 indexed citations

15.

Li, Xiao, Wei Gong, Xiaodong Lv, et al.. (2021). Cancer stage-dependent alterations in cell-free DNA in patients with colorectal cancer. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(1). 109–115. 5 indexed citations

16.

Yan, Liang, Kai Li, Zunyong Feng, et al.. (2020). lncRNA CERS6‐AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR‐125a‐5p to upregulate BAP1 expression. Molecular Carcinogenesis. 59(10). 1199–1208. 22 indexed citations

17.

Lin, Yusheng, Hongmei Dong, Wan‐Wan Lin, et al.. (2019). Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma. Clinical Cancer Research. 25(10). 3035–3045. 79 indexed citations

18.

Yang, Qingzhu, Kai Li, Lin Jiao, et al.. (2019). An Updated Review of Disulfiram: Molecular Targets and Strategies for Cancer Treatment. Current Pharmaceutical Design. 25(30). 3248–3256. 33 indexed citations

19.

Li, Kai, et al.. (2009). Study on genetic regulation of microsatellite loci gene of three inbred families of Wuzhishan Miniature pig.. Zhongguo nongye Kexue. 42(5). 1751–1760. 1 indexed citations

20.

Li, Kai, et al.. (1992). THE INHIBITION EFFECT OF SUBSTITUTED 2-CHLOROBENZOYL PHENYL UREA ON CHINTIN SYNTHESIS. Chinese Journal of Applied Chemistry. 9(4). 35–40.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact